Filing Details
- Accession Number:
- 0001849521-24-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-30 20:31:35
- Reporting Period:
- 2023-01-26
- Accepted Time:
- 2024-01-30 20:31:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1849521 | Nicole Sandford | C/O Aspira Women'S Health Inc 12117 Bee Caves Rd Bldg 3-100 Austin TX 78738 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-01-26 | 2,400 | $0.00 | 61,103 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Warrant (Right to Buy) | Acquisiton | 2024-01-26 | 2,400 | $0.00 | 2,400 | $4.13 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,400 | 2024-07-26 | 2029-07-26 | No | 4 | P | Direct |
Footnotes
- Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $4.255.